Skip to content
Abivax
EN
FR
About Abivax
Our Mission
Company History
Our Leadership
Contact Us
Our Science
Novel MOA
Obefazimod
Our Research
Our Pipeline
Publications
Investors
Overview
Press Releases
News
Share Price
Investor Documents
General Meeting
Corporate Presentation
EN
FR
News & Events
Press Coverage
2023
2022
2021
2020
2019
BioCentury
March 7, 2016
ABX464: Additional Phase IIa data
Reuters
February 29, 2016
Abivax updates on ABX464 study to treat HIV
Scrip
February 10, 2016
Video Interview: Armed With Promising Clinical Data, Abivax Seeks Partners
LabioTech
January 18, 2016
A Phase II HIV Antiviral from France Has Promising Results
1
2
